Profile
Christopher J.
M.
Taylor worked as a Vice President of Communications & Investor Relations at Oscient Pharmaceuticals Corp.
and Feinstein Kean Healthcare.
He also worked as a VP of Corporate Communications & Investor Relations at HeartWare International, Inc. from 2009 to 2016.
Taylor received his undergraduate degree from Syracuse University.
Former positions of Christopher J. M. Taylor
| Companies | Position | End |
|---|---|---|
| HEARTWARE INTERNATIONAL INC | Investor Relations Contact | 31/12/2015 |
Feinstein Kean Healthcare
 Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Corporate Officer/Principal | - |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Public Communications Contact | - |
Training of Christopher J. M. Taylor
| Syracuse University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
Feinstein Kean Healthcare
Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Commercial Services |
HeartWare International LLC
 HeartWare International LLC Medical SpecialtiesHealth Technology HeartWare International LLC is a medical device company, which engaged in the development and manufacturing of miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The company was founded on July 29, 2008 and is headquartered in Framingham, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher J. M. Taylor
